Calumet director sells 3,310 shares under 10b5-1

Calumet, Inc. director Daniel J. Sajkowski sold 3,310 shares of common stock in an open-market transaction.

Accepted by SEC EDGAR 04/02/2026 - 04:19 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Calumet, Inc. director Daniel J. Sajkowski sold 3,310 shares of common stock in an open-market transaction. The sale occurred on April 1, 2026 at a weighted average price of $34.46 per share, with individual trade prices ranging from $33.75 to $35.84.

The transaction was effected under a Rule 10b5-1 trading plan adopted on November 18, 2025, when Calumet, Inc. stock closed at $19.08 per share. After this sale, Sajkowski directly holds 81,958 shares of Calumet, Inc. common stock.

Insider Trade Summary

Net Seller: 3,310 shares

Net Sell 1 txn

Insider Sajkowski Daniel J

Role Director

Sold 3,310 shs ($114K)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share	3,310	$34.46	$114K

Holdings After Transaction: Common Stock, par value $0.01 per share — 81,958 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 per share to $35.84 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Key Figures

Shares sold: 3,310 shares Weighted average sale price: $34.46 per share Sale price range: $33.75–$35.84 per share +3 more

6 metrics

Shares sold 3,310 shares Open-market sale on April 1, 2026

Weighted average sale price $34.46 per share Common stock sale on April 1, 2026

Sale price range $33.75–$35.84 per share Prices for multiple sale transactions

Shares held after transaction 81,958 shares Direct ownership following the sale

Stock price at plan adoption $19.08 per share Closing price on Rule 10b5-1 plan adoption date

Transaction code S (sale) Non-derivative open-market sale

Key Terms

Rule 10b5-1 trading plan, weighted average price, Nasdaq Global Select Market, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported is a weighted average price. These shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Nasdaq Global Select Market market

"The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market"

A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.

open-market sale financial

"transaction_action": "open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CLMT director Daniel J. Sajkowski report?

Daniel J. Sajkowski reported selling 3,310 shares of Calumet, Inc. common stock. The sale was an open-market transaction at a weighted average price of $34.46 per share, with trade prices ranging from $33.75 to $35.84.

When did the latest Calumet (CLMT) insider sale by Daniel Sajkowski occur?

The reported insider sale by Daniel Sajkowski occurred on April 1, 2026. On that date he sold 3,310 shares of Calumet, Inc. common stock in open-market trades at a weighted average price of $34.46 per share.

How many CLMT shares does Daniel Sajkowski hold after this Form 4 sale?

After the reported sale, Daniel Sajkowski directly holds 81,958 shares of Calumet, Inc. common stock. This figure reflects his position following the 3,310-share open-market transaction disclosed in the Form 4 filing.

Was the CLMT insider sale by Daniel Sajkowski under a Rule 10b5-1 plan?

Yes. The sale was effected under a Rule 10b5-1 trading plan adopted by Daniel Sajkowski on November 18, 2025. On the plan adoption date, Calumet, Inc.’s closing stock price was $19.08 per share on the Nasdaq Global Select Market.

What price range did Daniel Sajkowski receive for his sold CLMT shares?

The reported price is a weighted average of $34.46 per share. According to the filing, the 3,310 Calumet, Inc. shares were sold in multiple transactions at prices ranging from $33.75 to $35.84 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sajkowski Daniel J

(Last) (First) (Middle)

1060 N CAPITOL AVE

SUITE 6-401

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	04/01/2026		S(1)		3,310	D	$34.46(2)	81,958	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 per share to $35.84 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

	/s/ Connor J. Egan, as attorney-in-fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)